A combination of two widely available anti-rheumatic drugs offers the first effective and affordable treatment for patients ...

Studies of obinutuzumab, a type II anti-CD20 antibody, have shown efficacy in the treatment of hematologic cancers and autoimmune diseases. An evaluation of the efficacy and safety of obinutuzumab in ...

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...

Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease in which lung tissue becomes scarred, making it hard to ...

Polymyalgia rheumatica is a common inflammatory disease characterized by pain and stiffness in the shoulders and hips. Glucocorticoids are the first-line treatment, but relapses and ...

Monthly rifampin-moxifloxacin-minocycline therapy lowers the risk for type 1 reactions in patients with Hansen disease, study shows.

The World Health Organization's director reports that five patients have recovered from a rare type of Ebola virus in eastern Congo, where a new treatment center has opened.

Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...

On May 16, 2026, the WHO Director-General Tedros Adhanom Ghebreyesus took the unprecedented step of declaring a Public Health Emergency of International Concern (PHEIC) without first convening an ...

BLD is caused by a nematode, or microscopic worm, that parasitizes the leaves of beech trees. While European beech are often planted as specimen trees, American beech (Fagus grandifolia) makes up ten ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, according to findings from two new trials.

Dupuytren’s disease is a progressive fibroproliferative disorder of the palmar fascia that leads to the formation of nodules and fibrous cords, causing fixed flexion deformities of the digits and ...